Form 4: Hims & Hers Health, Inc. Executive Acquires Restricted Stock Units
SEC Form 4 Filing
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., was granted 98,925 Restricted Stock Units (RSUs) on March 3, 2025, according to a Form 4 filing with the SEC.
Summary
- On March 3, 2025, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., acquired 98,925 Restricted Stock Units (RSUs).
- These RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU.
- The RSUs are subject to a 4-year service-based vesting schedule, with vesting occurring in substantially equal quarterly installments on March 15, June 15, September 15, and December 15, starting June 15, 2025.
- Following the transaction, Boughton directly owns 98,925 derivative securities.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, suggesting stability and alignment of interests. The sentiment is neutral to positive.
Positives
- The acquisition of RSUs by a key executive signals confidence in the company's future performance.
Future Outlook
The vesting schedule of the RSUs incentivizes the executive to remain with the company for the next four years.
Industry Context
Grants of restricted stock units are a common form of executive compensation in the health and wellness industry, aligning executive interests with shareholder value.
Comparison to Industry Standards
- Executive compensation packages, including RSU grants, are common in publicly traded companies like Hims & Hers Health, Inc.
- Comparable companies in the telehealth space, such as Teladoc Health and Amwell, also utilize equity-based compensation to incentivize their executives.
- The size and vesting schedule of the RSU grant are likely benchmarked against industry standards for similar roles and company performance.
Stakeholder Impact
- Shareholders may view the RSU grant as a positive incentive for the Chief Legal Officer to contribute to the company's long-term success.
- Employees may see this as a sign of the company's commitment to its leadership team.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of earliest transaction: Soleil Boughton acquired 98,925 Restricted Stock Units. |
| 03/05/2025 | Date of Form 4 filing. |
| 06/15/2025 | First Company Quarterly Vesting Date for the RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.